Vincenzo Adamo
Azienda Ospedaliera Ospedali Riuniti Papardo Piemonte(IT)
Publications by Year
Research Areas
HER2/EGFR in Cancer Research, Brain Metastases and Treatment, Lung Cancer Treatments and Mutations, Lung Cancer Research Studies, Advanced Breast Cancer Therapies
Most-Cited Works
- → Efficacy of T-DM1 for leptomeningeal and brain metastases in a HER2 positive metastatic breast cancer patient: new directions for systemic therapy - a case report and literature review(2018)48 cited
- → Gemcitabine and liposomal doxorubicin in the salvage treatment of ovarian cancer: Updated results and long-term survival(2005)41 cited
- → Efficacy of nab-paclitaxel plus trastuzumab in a long-surviving heavily pretreated HER2-positive breast cancer patient with brain metastases(2015)21 cited
- → Gemcitabine in epithelial ovarian cancer treatment: current role and future perspectives(2005)21 cited
- → Predictors of long-term response to abiraterone in patients with metastastic castration-resistant prostate cancer: a retrospective cohort study(2016)20 cited
- → Brain metastases in patients with non-small cell lung cancer: focus on the role of chemotherapy(2006)16 cited
- → Cisplatin, fotemustine and whole-brain radiotherapy in non-small cell lung cancer patients with asymptomatic brain metastases: A multicenter phase II study of the Gruppo Oncologico Italia Meridionale (GOIM 2603)(2010)14 cited
- → Induction chemotherapy with paclitaxel and cisplatin to concurrent radiotherapy and weekly paclitaxel in the treatment of loco-regionally advanced, stage IV (M0), head and neck squamous cell carcinoma. Mature results of a prospective study(2011)14 cited
- → Genomically matched therapy in advanced solid tumors: the randomized phase 2 ROME trial(2025)14 cited
- → Eribulin mesylate use as third-line therapy in patients with metastatic breast cancer (VESPRY): a prospective, multicentre, observational study(2019)13 cited